MASS 908 Devices Inc.
USHealthcareAs of 2026-07-10 16:00
Why MASS matters now
908 Devices Inc. (MASS) is a US stock in Healthcare. The latest InvestLog snapshot shows $8.10 with -0.37% on the session and $306.3M in market capitalization; recent performance reads 1-month +30.53% and YTD +68.57%.
The latest financial table shown here is Q1 2026, with revenue of $13.4M, net income of $-12.0M, and EPS of $-0.32. Investors can compare that operating picture with valuation signals such as P/E 12.96 and FCF yield -2.5%.
The latest indexable market news headline is "Volatus Aerospace to Showcase Multi-Domain Capabilities at MASS 2026" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Spoto Mark filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
12.96
PEG
0.10
P/B
2.43
P/S
5.79
EV/EBITDA
-10.22
DCF Value
$-9.53
FCF Yield
-2.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.0%
Operating Margin
-52.5%
Net Margin
-62.1%
ROE
-25.5%
ROA
-19.2%
ROIC
-20.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $13.4M | $-12.0M | $-0.32 |
| Q4 2025 | $17.4M | $4.3M | $0.10 |
| FY 2025 | $56.2M | $-36.6M | $0.54 |
| Q3 2025 | $14.0M | $-14.9M | $-0.41 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.64
908 Devices Inc. is an established technology company providing advanced mass spectrometry (Mass Spec) solutions. They develop specialized portable and benchtop instruments designed to analyze and identify unknown or hidden substances across various fields. Their products address needs in life sciences research, biopharmaceutical manufacturing, industrial biotechnology, forensic investigations, and related sectors. Key offerings include: The MX908, a handheld, battery-operated Mass Spec device capable of rapid on-site detection and identification of unknown gaseous, liquid, and solid materials. The Rebel, a compact desktop analyzer that delivers real-time data concerning the extracellular environment within bioprocesses. The ZipChip solution, a high-resolution, user-friendly separation platform engineered to optimize the preparation and analysis of samples for Mass Spec. With operations spanning the globe, 908 Devices Inc. serves markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was established in 2012 and is based in Boston, Massachusetts.